New drug injection tested for Tough-to-Treat skin cancer
NCT ID NCT00249262
Summary
This study tested a weekly injection called Taxoprexin in 30 patients with advanced skin melanoma that had spread to other parts of the body. The goal was to see if the treatment could shrink tumors, control the disease, and extend survival. Patients received the injections weekly for five weeks in a six-week cycle until the cancer progressed or side effects became too severe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.